Cited by 300RNA Research and SplicingRNA regulation and diseaseRNA and protein synthesis mechanisms

Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2

Open access
Zhang, Chaolin, Zhang, Zuo, Castle, John, Sun, Shuying, Johnson, Jason, Krainer, Adrian R., Zhang, Michael Q.·2008·Genes & Development

Abstract

The precise regulation of many alternative splicing (AS) events by specific splicing factors is essential to determine tissue types and developmental stages. However, the molecular basis of tissue-specific AS regulation and the properties of splicing regulatory networks (SRNs) are poorly understood. Here we comprehensively predict the targets of the brain- and muscle-specific splicing factor Fox-1 (A2BP1) and its paralog Fox-2 (RBM9) and systematically define the corresponding SRNs genome-wide. Fox-1/2 are conserved from worm to human, and specifically recognize the RNA element UGCAUG. We integrate Fox-1/2-binding specificity with phylogenetic conservation, splicing microarray data, and additional computational and experimental characterization. We predict thousands of Fox-1/2 targets with conserved binding sites, at a false discovery rate (FDR) of ∼24%, including many validated experimentally, suggesting a surprisingly extensive SRN. The preferred position of the binding sites differs according to AS pattern, and determines either activation or repression of exon recognition by Fox-1/2. Many predicted targets are important for neuromuscular functions, and have been implicated in several genetic diseases. We also identified instances of binding site creation or loss in different vertebrate lineages and human populations, which likely reflect fine-tuning of gene expression regulation during evolution.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.1703108

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among the 212 significant alternative splicing events, 36 had been defined by Zhang et al. as predicted targets of A2BP1/2, representing a highly significant overlap (p=2.2E-16).

    “Among these, 36 had been defined by Zhang et al. 19 as predicted targets of A2BP1/2 , which represents a highly significant overlap (p=2.2E-16).”
  • Known splicing regulators, including RBFOX and PTB family members, were associated with preferential exon inclusion or exclusion in a manner correlated with the expression and binding location of the RBP.

    “known splicing regulators, including RBFOX and PTB family members4, were associated with preferential exon inclusion or exclusion in a manner that correlated with the expression and binding location of the RBP”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, C., Zhang, Z., Castle, J., Sun, S., Johnson, J., Krainer, A. R., & Zhang, M. Q.
Affiliations
  • Cold Spring Harbor Laboratory (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • State University of New York (US)
Venue
Genes & Development
Published
2008-09-15
Volume
22
Issue
18
Pages
2550-2563
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2124182320
Cited by
300
References
63
Citations by year
2026: 3 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 16 · 2021: 9 · 2020: 9 · 2019: 7 · 2018: 12 · 2017: 16 · 2016: 11 · 2015: 18 · 2014: 32 · 2013: 27 · 2012: 27
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (GM74688, R01GM074688)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
Keywords
A2BP1, alternative splicing, splicing regulatory network, tissue-specific splicing, binding site prediction, exon recognition, binding site evolution, phylogenetic conservation
MeSH terms
RNA Splicing Factors, Binding Sites, Gene Expression Regulation, HeLa Cells, Humans, Repressor Proteins, RNA-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review